FindTrial
Sign In

Population Pharmacokinetic Study of Vancomycin/Meropenem in Chinese Extremely Preterm Infants/Very Low Birth Weight Infants

Population Pharmacokinetic Study of Vancomycin/Meropenem in Chinese Extremely Preterm Infants/Very Low Birth Weight Infants

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600118716
Enrollment
Unknown
Registered
2026-02-10
Start date
2026-03-01
Completion date
Unknown
Last updated
2026-02-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neonatal sepsis

Interventions

Meropenem group:None
Vancomycin group:None

Sponsors

Hunan Provincial Maternal and Child Health Care Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Gestational age =2 days.

Exclusion criteria

Exclusion criteria: 1. Missing clinical information records; 2. Treatments received by the pediatric patients during the study may affect the metabolism of vancomycin/meropenem, such as renal replacement therapy; 3. Patients lacking serum creatinine and other renal function or biochemical indicator data during administration.

Design outcomes

Primary

MeasureTime frame
Trough concentration;—

Countries

China

Contacts

Public ContactYulu Zhou

Hunan Provincial Maternal and Child Health Care Hospital

yulu0028@126.com+86 731 8433 2251

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 19, 2026